# Ginkgo Bioworks Holdings Inc. (DNA) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$315M |
| 2024 | -$560M |
| 2023 | -$864M |
| 2022 | -$2.21B |
| 2021 | -$1.83B |
| 2020 | -$137M |
| 2019 | -$72M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$71M |
| 2025-09-30 | -$90M |
| 2025-06-30 | -$66M |
| 2025-03-31 | -$81M |
| 2024-09-30 | -$55M |
| 2024-06-30 | -$223M |
| 2024-03-31 | -$178M |
| 2023-09-30 | -$286M |
| 2023-06-30 | -$184M |
| 2023-03-31 | -$216M |
| 2022-09-30 | -$655M |
| 2022-06-30 | -$648M |
| 2022-03-31 | -$675M |
| 2021-09-30 | -$27M |
| 2021-06-30 | -$60M |
| 2021-03-31 | -$57M |
| 2020-09-30 | -$34M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/DNA/operating-income)